These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6303861)

  • 1. Multiple actions of phencyclidine: discriminant structure-activity relationships from molecular conformations and assay conditions.
    Weinstein H; Maayani S; Pazhenchevsky B
    Fed Proc; 1983 Jun; 42(9):2574-8. PubMed ID: 6303861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and properties of phencyclidine-binding sites in nervous tissues.
    Vincent JP; Bidard JN; Lazdunski M; Romey G; Tourneur Y; Vignon J
    Fed Proc; 1983 Jun; 42(9):2570-3. PubMed ID: 6303860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some structure activity relationships of phencyclidine derivatives as anticholinergic agents in vitro and in vivo.
    Maayani S; Weinstein H
    Prog Clin Biol Res; 1979; 27():91-106. PubMed ID: 424435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscle.
    El-Fakahany EE; Triggle DJ; Eldefrawi AT; Eldefrawi ME
    J Pharmacol Exp Ther; 1984 May; 229(2):447-54. PubMed ID: 6325665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of phencyclidine with ion channels of nerve and muscle: behavioral implications.
    Albuquerque EX; Aguayo LG; Warnick JE; Ickowicz RK; Blaustein MP
    Fed Proc; 1983 Jun; 42(9):2584-9. PubMed ID: 6303862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
    Aguayo LG; Weinstein H; Maayani S; Glick SD; Warnick JE; Albuquerque EX
    J Pharmacol Exp Ther; 1984 Jan; 228(1):80-7. PubMed ID: 6319672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine (PCP) selectively blocks certain presynaptic potassium channels.
    Blaustein MP; Bartschat DK; Sorensen RG
    NIDA Res Monogr; 1986; 64():37-51. PubMed ID: 2423875
    [No Abstract]   [Full Text] [Related]  

  • 8. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
    Contreras PC; Quirion R; O'Donohue TL
    NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
    El-Fakahany EE; Eldefrawi AT; Murphy DL; Aguayo LG; Triggle DJ; Albuquerque EX; Eldefrawi ME
    Mol Pharmacol; 1984 May; 25(3):369-78. PubMed ID: 6328263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neurosci Res; 2007 May; 85(6):1358-63. PubMed ID: 17342780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rigid phencyclidine analogues. Binding to the phencyclidine and sigma 1 receptors.
    Moriarty RM; Enache LA; Zhao L; Gilardi R; Mattson MV; Prakash O
    J Med Chem; 1998 Feb; 41(4):468-77. PubMed ID: 9484497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies of phencyclidine derivatives in rats.
    Cone EJ; McQuinn RL; Shannon HE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):147-53. PubMed ID: 6694098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine (PCP) and derivatives: pharmacology and structure-activity relationships [proceedings].
    Maayani S; Weinstein H; Glick SD; Meibach RC
    Psychopharmacol Bull; 1980 Oct; 16(4):57-9. PubMed ID: 7454940
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of barbiturates, phencyclidine, ketamine and analogs on cerebral circulation and cerebrovascular muscle.
    Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):169-84. PubMed ID: 6400429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sites of action of phencyclidine. III. Interactions with muscarinic receptors.
    Aronstam RS; Eldefrawi ME; Eldefrawi AT; Albuquerque EX; Jim KF; Triggle DJ
    Mol Pharmacol; 1980 Sep; 18(2):179-84. PubMed ID: 7421791
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
    Aguayo LG; Warnick JE; Maayani S; Glick SD; Weinstein H; Albuquerque EX
    Mol Pharmacol; 1982 May; 21(3):637-47. PubMed ID: 6287200
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of phencyclidine on cardiac action potential: pH dependence and structure-activity relationships.
    D'Amico GA; Kline RP; Maayani S; Weinstein H; Kupersmith J
    Eur J Pharmacol; 1983 Apr; 88(4):283-90. PubMed ID: 6602710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
    Kamenka JM; Chiche B; Goudal R; Geneste P; Vignon J; Vincent JP; Lazdunski M
    J Med Chem; 1982 Apr; 25(4):431-5. PubMed ID: 6279847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.